E547* FL USP7 Citations (2)
Originally described in: Functional spectrum of USP7 pathogenic variants in Hao-Fountain syndrome: Insights into the enzyme's activity, stability, and allosteric modulation.Korchak EJ, Sharafi M, Jaen Maisonet I, Salazar-Chaparro A, Semenova IV, Khan H, O'Neil AL, Caro P, Schaaf CP, Buhrlage SJ, Bezsonova I Proc Natl Acad Sci U S A. 2025 Sep 30;122(39):e2510252122. doi: 10.1073/pnas.2510252122. Epub 2025 Sep 22. PubMed Journal
Articles Citing E547* FL USP7
| Articles |
|---|
| bioRxiv: Functional Spectrum of USP7 Pathogenic Variants in Hao-Fountain Syndrome: Insights into the Enzyme's Activity, Stability, and Allosteric Modulation. Korchak EJ, Sharafi M, Maisonet IJ, Caro P, Schaaf CP, Buhrlage SJ, Bezsonova I. bioRxiv [Preprint]. 2025 Mar 20:2025.03.20.644318. doi: 10.1101/2025.03.20.644318. PubMed |
| USP2-mediated PPARgamma stabilization promotes hepatocellular carcinoma progression and M2 macrophage polarization via oleic acid. Cao J, Chen K, Hu K, Mi X, Pan Y, Xiao D, Liu S, Xiao L, Zhou L, Tao Y, Tang J. J Immunother Cancer. 2025 Nov 4;13(11):e012721. doi: 10.1136/jitc-2025-012721. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.